Creating a new paradigm for management of yeast infections

Yeasts are unicellular microorganisms classified within the Fungi kingdom. They are well known for their use in baking, winemaking and beer brewing fermentation, but some species of yeast are opportunistic pathogens that can cause infections in humans. "Today, yeast infections are poorly understood, difficult to diagnose, and are becoming increasingly frequent and serious, affecting over 300 million people worldwide. Fungal infections kill as many people as Malaria does every year, and are a problem of growing concern for patients with a debilitated immune system such as those with cancer or HIV," states Toni Gabaldón, coordinator of the OPATHY network. "Some of the most urgent problems come from an increase in resistance to anti-fungal drugs and from the lack of fast and efficient diagnostic tools to determine appropriate treatments. Early detection of the species underlying the infection is key for a successful treatment. Researchers at this international training network will endeavour to find innovative ways of doing this in a faster and more accurate manner," Gabaldón explains.

The European Innovation Training Network "OPATHY" plans to create a new paradigm for the management of yeast infections. The immediate goal is to rapidly and accurately diagnose yeast diseases by means of innovative omics that will result in improved treatment strategies. OPATHY will explore the potential of next-generation high-throughput technologies, including genomics, transcriptomics and proteomics, to study the interactions of infectious yeasts (e.g. Candida and Cryptococcus sp.) with our body, and to develop new diagnostic tools to monitor yeast infections in the clinic.

The OPATHY Project, awarded with more than 3 million Euros, is a Marie-Sk?odowska-Curie Innovative Training Network funded by the European Commission under the H2020 Framework Program. The project brings together researchers in Spain, the Netherlands, Ireland, Germany, Austria, United Kingdom and Belgium including both academic and private sector partners. After the official kick-off meeting the past 3rd of September at CRG, OPATHY opens today a call to recruit 13 PhD students for the different laboratories of the network. "We brought together the main experts in diverse fields, from technology developers to researchers and medical doctors in the clinic. This setting prompts to innovation and translation of basic research to practical solutions in the clinic. A really inspiring and rewarding environment to be trained in as a scientist of the future," Toni declares, who is an ICREA research professor and principal investigator at the Centre for Genomic Regulation (CRG) in Barcelona (Spain).

The selected students will obtain multidisciplinary theoretical and practical advanced training in the areas of high-throughput post-genomics technologies, host-pathogen interactions, and molecular diagnosis of yeast infectious diseases, working at the interface of the academic labs, the industry and the clinic. The final aim is to train the future generation of research leaders capable of performing outstanding translational and innovative research by devising original scientific and clinical strategies based on state-of-the-art technologies. To achieve this objective, the trainees will work on individual research projects that will be collaborative and integrated in the overall OPATHY interdisciplinary research. Overall, the well-balanced, multi-sectorial and multidisciplinary OPATHY network will provide a vibrant and stimulating research and training environment.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Keto diet enhances fungal meningitis treatment